mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.004 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.38 |
0.004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.005 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.005 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.005 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.006 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.006 |